Date of Document: March 24, 2023
CURRICULUM VITAE

Susanne M. Cabrera MD
Associate Professor
Department of Pediatrics
Division of Endocrinology

OFFICE ADDRESS:
Children's Corporate Center
999 N 92 St
Milwaukee, WI 53226
Phone: 414-266-6750
Fax: 414-266-6749

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Pediatric Endocrinology
11/13/2013
12/19/2024
   
AWARDS AND HONORS:
2021 Teaching Pin, Department of Pediatrics, Medical College of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2011 - Present American Diabetes Association (Member)
2014 - Present American Academy of Pediatrics

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
01/2019 - Present Deputy Editor, Pediatrics Review and Education Program (PREP) Endocrinology Editorial Board, American Academy of Pediatrics (3-year term)
Editorial Board
07/2015 - 12/2018 PREP Endocrinology Editorial Board, American Academy of Pediatrics
01/2022 - 12/2023 Editorial Board, The Journal of Clinical Endocrinology & Metabolism
Journal Review
11/2013 - Present ad hoc International Journal of Pediatric Endocrinology
05/2014 - Present ad hoc Pediatric Diabetes
03/2020 - Present ad hoc Journal of Clinical Endocrinology and Metabolism
03/2021 - Present current ad hoc Diabetes Care

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2012 - Present Member, Children's Research Institute, Developmental Genetics and Genomics Research Unit, Children's Hospital of Wisconsin
2012 - Present Member, Max McGee National Research Center for Juvenile Diabetes, Medical College of Wisconsin
2014 - Present Grant Reviewer, Children's Research Institute Intramural Pilot Grant, Children's Hospital of Wisconsin
2014 - Present Grant Reviewer, Clinical Translational Science Institute Pilot Grant, Southwestern Wisconsin CTSI
2017 - 2020 Invited Member, Medical Advisor Council, Type One Nation Summit, Southeastern Wisconsin JDRF
2017 - 2020 Invited Member, Medical Advisor Council, Type One Nation Summit, Southeastern Wisconsin JDRF
2017 - 2019 Invited Member, Board of Directors, Midwest Pediatric Endocrine Society
2018 - Present ad hoc member, TrialNet Publications and Presentations Committee, TrialNet Consortium
2018 Invited Reviewer, We care Fund Faculty Seed Grants, We Care Fund Scientific Review Committee, Department of Surgery, Medical College of Wisconsin
2020 - Present Member, Southeast Wisconsin Community Leadership Board, American Diabetes Association
2020 - Present Co-chair, Underrepresented Minority Recruitment and Retention Committee, Type 1 Diabetes TrialNet Consortium
2021 Member, NIH Special Review Panel, Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes and Related Research

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
07/01/2015 - 06/30/2018 Member, PREP Endocrinology Board, American Academy of Pediatrics
2018 - Present Member, TrialNet Publications and Presentations Committee
2020 - Present Co-Chair, Underrepresented Minority Recruitment and Retention Committee, Type 1 Diabetes TrialNet Consortium
2021 Member, NIH Special Review Panel, Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research, NIH

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
TrialNet Pathway to Prevention (Natural History) Study of the Development of Type 1 Diabetes
Source:
NIDDK, NIAID, NICHD, NCRR, JDRF, ADA
Role:
Principal Investigator
PI:
Susanne M Cabrera
Dates:
07/01/2015 - Present
Direct Funds:
$80,000
  
Title:
Probiotic normalization of innate inflammation in T1D
Source:
American Diabetes Association
Role:
Co-Investigator
PI:
Martin J. Hessner
Dates:
01/01/2019 - 12/31/2021
Direct Funds:
$600,000
  
Title:
Plasma-induced signatures as a measure of disease heterogeneity and immunomodulation in T1D clinical trials
Source:
National Institutes of Health (NIDDK)
Role:
Co-Investigator
PI:
Martin J. Hessner
Dates:
03/01/2020 - 12/31/2023
Direct Funds:
$1,900,000
  
Title:
TrialNet Hydroxychloroquine for prevention of abnormal glucose tolerance and diabetes in individuals at-risk for type 1 diabetes mellitus
Source:
NIDDK
Role:
Site Investigator
PI:
Polley Bingley MD and Jane Buckner MD
Dates:
09/25/2020 - 12/31/2022
Direct Funds:
$5,000
  
Title:
Cardiometabolic effects of gender-affirming testosterone therapy in transgender boys and men
Source:
Advancing a Healthier Wisconsin
Role:
Principal Investigator
PI:
Susanne M. Cabrera
Dates:
07/01/2021 - 06/30/2024
Direct Funds:
$250,000
  
Prior
Peer Review
Title:
Intestinal Permeability as a Risk Factor for Type 1 Diabetes
Source:
Children's Research Insitute
Role:
Principal Investigator
PI:
Susanne Cabrera
Dates:
04/01/2014 - 03/29/2015
Direct Funds:
$50,000
  
Title:
Intestinal Permeability as a Risk Factor for Type 1 Diabetes
Source:
Children's Research Institute Pilot Innovative Research Award
Role:
PI
Dates:
04/01/2014 - 03/29/2015
Direct Funds:
$50,000
  
Title:
A 26-week open label, randomised, 2-armed, parallel group, multi-centre trial -investigating efficacy and safety of insulin detemir versus insulin Neutral Protamine Hagedorn in combination with metformin and diet/exercise on glycaemic control in children and adolescents with type 2 diabetes insufficiently controlled on metformin ± other oral antidiabetic drug(s) ± basal insulin
Source:
Novo Nordisk
Role:
Principal Investigator
PI:
Susanne Cabrera
Dates:
03/05/2015 - 03/01/2016
  
Title:
Targeting Polyamines using DFMO in Persons with Type 1 Diabetes
Source:
Juvenile Diabetes Research Foundation
Role:
site investigator
PI:
Linda DiMeglio
Dates:
12/01/2015 - 12/31/2018
Direct Funds:
$1,300,000
  
Title:
Modulation of type 1 diabetes susceptibility through VSL#3 probiotic-induce alterations in the intestinal microbiota
Source:
Children's Research Institute
Role:
Principal Investigator
PI:
Susanne Cabrera
Dates:
01/01/2018 - 12/31/2018
Direct Funds:
$1,300,000
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
Cabrera SM, Premature Ovarian Insufficiency, Endocrine Grand Rounds, Indiana University School of Medicine, 05/10/2010
Cabrera SM, The beta cell as therapeutic target in type 1 and type 2 diabetes, Endocrine Grand Rounds, Indiana University School of Medicine, 01/01/2011
Cabrera SM, Prediction of type 1 diabetes mellitus and prevention strategies, Department of Pediatrics Grand Rounds, Indiana University School of Medicine and Riley Hospital for Children, 07/18/2012
Cabrera SM, Current and novel prediction techniques of type 1 diabetes mellitus and on-going prevention strategies, RIP/Diabetes Journal Club, Medical College of Wisconsin, 10/02/2012
Cabrera SM, Prediction and Prevention of Type 1 Diabetes: Where we're at and where we're going, Department of Pediatrics Grand Rounds, Medical College of Wisconsin, 11/15/2012
Cabrera SM, Thyroid disease in the adolescent, Section of Adolescent Medicine Weekly Academic Conference, Medical College of Wisconsin, 02/15/2013
Cabrera SM, Perioperative Diabetes Management, Pediatric Surgery Basic Science Conference, Medical College of Wisconsin, 08/27/2013
Cabrera SM, 5-alpha-reductase deficiency: a case report, Disorders of Sexual Development Multidisciplinary Conference, Children's Hospital of Wisconsin, 08/29/2013
Cabrera, SM, Medical care of transgender children, Division of Adolescent Medicine Grand Rounds, Children's Hospital of Wisconsin, 01/12/2017
Cabera SM, Care of gender-non-conforming and transgender youth, Division of Psychiatry Grand Rounds, Children’s Hospital of Wisconsin, 02/15/2018
Cabrera SM, GI-mediated interventions to reduce T1D susceptibility, Children’s Research Institute Grand Rounds (CME), Children’s Hospital of Wisconsin, 02/23/2018
Cabrera SM, The CHW Gender Health Clinic: providing comprehensive care to gender non- conforming and transgender youth, Department of Pediatric Grand Rounds (CME), Children’s Hospital of Wisconsin, 08/24/2018
Cabrera SM, Providing specialty care to gender non-conforming and transgender youth, Division of Allergy/Immunology Grand Rounds, Children’s Hospital of Wisconsin, 09/14/2018
Cabrera SM, Clinical trials to alter T1D susceptibility in at-risk children, Center for Advancing Population Science, Medical College of Wisconsin, 02/18/2019
Cabrera SM, Gender Health Care at Children’s Hospital of Wisconsin, Social Work Noon Conference Series, Children’s Hospital of Wisconsin, 05/29/2019
Cabrera SM, Care of Gender Diverse Youth, CAP Didactics, Department of Pediatric Psychiatry, Medical College of Wisconsin, 04/29/2020
 
Regional
Cabrera SM, Diabetes in the Teen, Best Practices Conference, Glacier Canyon Lodge, Wisconsin Dells, WI, USA, 03/08/2013
Cabrera SM, Clinical Trials in Type 1 Diabetes, World Diabetes Day - JDRF Southeastern Wisconsin Chapter, Blue Harbor Resort and Conference Center, Sheboygan, Wisconsin, 11/14/2015
Cabrera SM, Gender Identity and Gender Dysphoria, Wisconsin Academy of Physician Assistants Spring Conference, Madison, WI, 04/06/2022
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
National
Monnier (CABRERA) SM, Rapid and controlled polymerization of lactide by structurally characterized ferric alkoxides, National American Chemical Society Undergraduate Symposium, San Diego, CA, USA, 10/01/2001 - Present
Cabrera SM, Behzadi JM, DiMeglio LA, and Walvoord EC, Five-year glycemic control in children with type 1 diabetes: does the type of initial education matter?, Endocrine Society National Meeting, San Francisco, CA, USA, 06/20/2008 - Present
Cabrera SM, Alvarez R, Kaefer MN, Eugster EA, and Nebesio TD, Unexpected finding of intact distal vagina in an infant with mixed gonadal dysgenesis, Endocrine Society Annual Meeting, Poster Session, San Diego, CA, USA, 06/15/2010 - Present
Cabrera SM, Tersey SA, Morris M, Nadler JL, and Mirmira RG, Combination therapy with growth-promoting and pro-differentiation agents increases beta cell mass and reduces insulitis in diabetic NOD mice., American Diabetes Association 71st Scientific Meeting, Guided Audio Tour Presentation, San Diego, CA, USA, 07/20/2011 - Present
Cabrera SM, Eugster EA, Incidence and defining characteristics of pseudoprecocious puberty in children with severe primary hypothyroidism., Pediatric Endocrine Society Meeting, Presidential Poster Session and Poster Symposium, Boston, MA, USA, 04/01/2012 - Present
 

COMMITTEE SERVICE:
Medical College of Wisconsin
09/2014 - Present Director, Clinical Competency Committee, Pediatric Endocrinology Fellowship Program, Endocrinology, Pediatrics, Medical College of Wisconsin
08/2015 - Present Member, Scholarly Oversight Committee, Pediatric Endocrinology Fellowship Program, Endocrinology, Pediatrics, Medical College of Wisconsin
01/2021 Member, Internal Division Funding Review Committee, Endocrinology, Pediatrics, Medical College of Wisconsin
10/2021 - Present Member, Scholarly Oversight Committee, Pediatric Hospitalist Fellow, Pediatrics
 
Hospital
09/2016 - 09/2017 Member, LEAN Committee for Improved Efficiency and Patient Care, Endocrinology, Pediatrics, Children’s Hospital of Wisconsin Diabetes and Endocrine Clinic
07/2018 Member, Sexual Orientation and Gender Identity EPIC Committee, Endocrinology, Pediatrics, Children’s Hospital of Wisconsin
09/2018 - 01/2019 Content Expert, Gender Identity Education Project, Endocrinology, Pediatrics, Children’s Hospital of Wisconsin
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Resident and Fellow Education
09/01/2012 - Present Ad lib mentor for pediatric residents in preparation of endocrine-based cases for Professor Rounds and Med Peds Noon Conference (approximately 2-3 times/year)
09/2015 - 12/2016 Staff pediatric endocrinology fellows during their continuity diabetes clinics (12/year)
 

EXTRAMURAL TEACHING:
Community/Lay Public
05/2013 - Present Medical College of Wisconsin/Children's Hospital of Wisconsin, Informational talks about type 1diabetes research opportunities at MCW/CHW (educational booths at community events including JDRF walks, community adult endocrinology groups, conferences, and diabetes summer camps (4/year))
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Fisher MM, Cabrera SM, Imel EA. Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients. Endocrinol Diabetes Metab Case Rep. 2015;2015:150040. PMCID: PMC4496565
2. Chen YG, Cabrera SM, Jia S, Kaldunski ML, Kramer J, Cheong S, Geoffrey R, Roethle MF, Woodliff JE, Greenbaum CJ, Wang X, Hessner MJ. Molecular signatures differentiate immune states in type 1 diabetic families. Diabetes. 2014 Nov;63(11):3960-73. PMCID: PMC4207392
3. Cabrera SM, Bright GM, Frane JW, Blethen SL, Lee PA. Age of thelarche and menarche in contemporary US females: a cross-sectional analysis. J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):47-51. PMCID: PMC4137967
4. Cabrera SM, Colvin SC, Tersey SA, Maier B, Nadler JL, Mirmira RG. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes. Clin Exp Immunol. 2013 Jun;172(3):375-82. PMCID: PMC3646436
5. Cabrera SM, Rogol AD. Testosterone exposure in childhood: discerning pathology from physiology. Expert Opin Drug Saf. 2013 May;12(3):375-88.
6. Cabrera SM, Srivastava NT, Behzadi JM, Pottorff TM, Dimeglio LA, Walvoord EC. Long-term glycemic control as a result of initial education for children with new onset type 1 diabetes: does the setting matter? Diabetes Educ. 2013;39(2):187-94. PMCID: PMC4780749
7. Cabrera SM, DiMeglio LA, Eugster EA. Incidence and characteristics of pseudoprecocious puberty because of severe primary hypothyroidism. J Pediatr. 2013 Mar;162(3):637-9. PMCID: PMC4070005
8. Cabrera SM, Srivastava NT, Behzadi JM, Pottorff TM, Dimeglio LA, Walvoord EC. Long-term glycemic control as a result of initial education for children with new onset type 1 diabetes: does the setting matter? Diabetes Educ. 2013;39(2):187-94. PMCID: PMC4780749
9. Tersey SA, Nishiki Y, Templin AT, Cabrera SM, Stull ND, Colvin SC, Evans-Molina C, Rickus JL, Maier B, Mirmira RG. Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes. 2012 Apr;61(4):818-27. PMCID: PMC3314371
10. Cabrera SM, Alvarez R, Kaefer MN, Eugster EA, Nebesio TD. Unexpected finding of an intact distal vagina in an infant with mixed gonadal dysgenesis. J Pediatr Endocrinol Metab. 2011;24(9-10):831-3. PMCID: PMC4094021
11. Shull J, Monnier (CABRERA) SM, Solomon SS, Buss N, and Gerling IC. Proteome of H-411E (Liver) cells exposed to insulin and TNF-alpha: Analysis of proteins involved in insulin resistance. J Lab Clin Med 2005;145(5):275-83.
12. Solomon SS, Buss N, Shull J, Monnier S, Majumdar G, Wu J, Gerling IC. Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance. J Lab Clin Med. 2005 May;145(5):275-83.
13. Baruah H, Rector CL, Monnier SM, Bierbach U. Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates. Biochem Pharmacol. 2002 Jul 15;64(2):191-200.
14. Baruah H, Rector CL, Monnier(CABRERA) SM, Bierbach U. Mechanism of action of non-cisplatin type DNA-targeted platinum anticancer agents: DNA interactions of novel acridinylthioureas and their platinum conjugates. Biochem Pharmacol. 2001;64(2): 191-200.
15. O'Keefe B, Monnier (CABRERA) SM, Hillmyer M, Tolman WB. Rapid and Controlled Polymerization of Lactide by Structurally Characterized Ferric Alkoxides. J Am Chem Soc 2001;123: 339-40.
16. O'Keefe BJ, Monnier SM, Hillmyer MA, Tolman WB. Rapid and controlled polymerization of lactide by structurally characterized ferric alkoxides. J Am Chem Soc. 2001 Jan 17;123(2):339-40.
17. Cabrera SM, Wang X, Chen YG, Jia S, Kaldunski ML, Greenbaum CJ, Type 1 Diabetes TrialNet Canakinumab Study Group, Mandrup-Poulsen T, AIDA Study Group, Hessner MJ. Interleukin-1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset. Eur J Immunol. 2016 Apr;46(4):1030-46. PMCID: PMC4828314
18. Cabrera SM, Chen YG, Hagopian WA, Hessner MJ. Blood-based signatures in type 1 diabetes. Diabetologia. 2016 Mar;59(3):414-25. PMCID: PMC4744128
19. Henschel AM, Cabrera SM, Kaldunski ML, Jia S, Geoffrey R, Roethle MF, Lam V, Chen YG, Wang X, Salzman NH, Hessner MJ. Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and β-cell chemokine expression associated with autoimmune diabetes susceptibility. PLoS One. 2018;13(1):e0190351. PMCID: PMC5749787
20. Fawley J, Koehler S, Cabrera S, Lam V, Fredrich K, Hessner M, Salzman N, Gourlay D. Intestinal alkaline phosphatase deficiency leads to dysbiosis and bacterial translocation in the newborn intestine. J Surg Res. 2017 Oct;218:35-42.
21. Narala B, Cabrera SM. Short stature The 5-Minute Pediatric Consult, 8th Edition. 1 January 2018:844-845.
22. Hessner MJ, Cabrera SM. Broadening Our Understanding Type 1 Diabetes Heterogeneity by Exploring Effects of Race/Ethnicity on Disease Trajectory. J Clin Endocrinol Metab. 2020 Dec 01;105(12):e4961-3. PMCID: PMC7531905
23. Walch AM, Cobb CE, Tsaih SW, Cabrera SM. The medical transition of young adults with type 1 diabetes (T1D): a retrospective chart review identifies areas in need of improvement. Int J Pediatr Endocrinol. 2020;2020:10. PMCID: PMC7254679
24. Wolfgram PM, Cabrera SM. Youth Along the T2D Risk Continuum Remain Concerningly Refractory to Therapeutic Interventions. J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2803-e2805. PMCID: PMC8208664
25. Cabrera SM, Engle S, Kaldunski M, Jia S, Geoffrey R, Simpson P, Szabo A, Speake C, Greenbaum CJ, Type 1 Diabetes TrialNet CTLA-4 Ig (Abatacept) Study Group, Chen YG, and Hessner MJ. Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent onset type 1 diabetes. Diabetologia.2018;61(11):2356-2370.
26. Cabrera SM, Engle S, Kaldunski M, Jia S, Geoffrey R, Simpson P, Szabo A, Speake C, Greenbaum CJ, Type 1 Diabetes TrialNet CTLA4-Ig (Abatacept) Study Group, Chen YG, Hessner MJ. Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes. Diabetologia. 2018 Nov;61(11):2356-2370. PMCID: PMC6182660
27. Fanning B, Narala B, Cabrera SM. Obtundation and respiratory depression during diabetic ketoacidosis. Pediatr Rev. Accepted for publication
28. Cabrera SM., Coren AT, Pant T, Ciecko AE, Jia S, Roethle MF, Simpson PM, Atkinson SN, Salzman NH, Chen YG, Hessner MJ. 2022. Probiotic normalization of systemic inflammation in siblings of Type 1 diabetes patients: An open-label pilot study. Scientific Reports. 12(1):3306. doi: 10.1038/s41598-022-07203-6. PMID: 35228584.
29. Sargin P, Roethle MF, Jia S, Pant T, Ciecko AE, Atkinson SN, Salzman NH, Teng RJ, Chen YG, Cabrera SM, Hessner MJ. <i>Lactiplantibacillus plantarum</i> 299v supplementation modulates β-cell ER stress and antioxidative defense pathways and prevents type 1 diabetes in gluten-free BioBreeding rats. Gut Microbes. 2022;14(1):2136467. PMCID: PMC9586621
30. Cabrera SM, Coren AT, Pant T, Ciecko AE, Jia S, Roethle MF, Simpson PM, Atkinson SN, Salzman NH, Chen YG, Hessner MJ. Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot study. Sci Rep. 2022 Feb 28;12(1):3306. PMCID: PMC8885673
 
Books, Chapters, and Reviews
1. Cabrera SM, Henschel AM, Hessner MJ. Innate inflammation in type 1 diabetes. Transl Res. 2016 Jan;167(1):214-27. PMCID: PMC4626442
2. Kashmiri, HK, and SM Cabrera. 'Short Stature'. The 5 Minute Pediatric Consult Standard. Ed. Michael Cabana. 7th ed. New York: Wolters-Kluwer, 2015.
3. Cabrera SM, Rigby MR, Mirmira RG. Targeting regulatory T cells in the treatment of type 1 diabetes mellitus. Curr Mol Med. 2012 Dec;12(10):1261-72. PMCID: PMC3709459
4. Cabrera SM, Henschel AM, and Hessner MJ. Innate inflammation in type 1 diabetes. Trans Res. 2015 Apr 29. Epub ahead of print.
5. Cabrera SM, Rogol AD Testosterone exposure in childhood: discerning pathology from physiology. Expert Opin Drug Saf. 2013 May;12(3):375-88
6. Cabrera SM, Chen YG, Hagopian WA, Hessner MJ Blood-based signatures in type 1 diabetes. Diabetologia. 2016 Mar;59(3):414-25
7. Narala B, Cabrera SM. ‘Short Stature’. The 5 Minute Pediatric Consult Standard. Ed. Michael Cabana. 8th ed. New York: Wolters-Kluwer, 2018.
8. Hessner MJ, Cabrera SM. Broadening our understanding of type 1 diabetes heterogeneity by exploring effects of race/ethnicity on disease trajectory. J Clin Endocrinol Metab. 2020 Dec 1:105(12):e4961-3. PMID 32542394. (invited commentary)
9. Wolfgram PM, Cabrera SM. Youth along the T2D risk continuum remain concerningly refractory to therapeutic interventions. J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2803-e2805. (invited commentary)
10. Cabrera SM. Medfyle Endocrine Society, Expert Invited Commentary and Podcast in response to “Fat mass accretion from birth to 5 years and metabolic homeostasis in childhood: The Healthy Start Study (Sauder)” in JCEM May 2021
11. Cabrera SM. Medfyle American Diabetes Association, Expert Invited Commentary, Podcast, and Clinical Case Presentation in response to “Uncovering pathways to personalized therapies in type 1 diabetes (Linsley)” in Diabetes April 2021.
12. Cabrera SM. “'Short Stature'. The 5 Minute Pediatric Consult Standard. Ed. Michael Cabana. 9th ed. New York: Wolters-Kluwer, 2022.